List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 26 studies with search of: Hereditary Neuropathies
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
Condition: Leber's Hereditary Optic Neuropathy
Interventions: Drug: Idebenone;   Drug: Placebo
2 Recruiting A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)
Condition: Optic Atrophy, Hereditary, Leber
Intervention: Drug: curcumin
3 Completed Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Motor and Sensory Neuropathies
Interventions: Drug: Placebo;   Drug: ascorbic acid
4 Enrolling by invitation Transcorneal Electrical Stimulation Therapy for Retinal Disease
Conditions: Retinitis Pigmentosa;   Macula Off;   Primary Open Angle Glaucoma;   Hereditary Macular Degeneration;   Treated Retina Detachment;   Retinal Artery Occlusion;   Retinal Vein Occlusion;   Non-Arteriitic-Anterior-Ischemic Optic-Neuropathy;   Hereditary Autosomal Dominant Optic Atrophy;   Dry Age Related Macular Degeneration;   Ischemic Macula Edema
Interventions: Device: Transcorneal Electrical Stimulation;   Device: DTL-electrode attached without energy
5 Recruiting Study of Inherited Neurological Disorders
Conditions: Ataxia;   Motor Neuron Disease;   Muscular Disease;   Muscular Dystrophy;   Peripheral Nervous System Disease
Intervention:
6 Completed Phenotype/Genotype Correlations in Neuromuscular Disorders
Condition: Neuromuscular Disease
Intervention:
7 Recruiting Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
Conditions: Chronic Optic Nerve Atrophy;   Non-Arteritic Anterior Ischemic Optic Neuropathy
Intervention: Drug: QPI-1007 at various doses
8 Recruiting Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Conditions: Arteriovenous Malformation;   Hereditary Hemorrhagic Telangiectasia;   Hematochezia;   Melena
Intervention: Drug: Thalidomide
9 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
10 Active, not recruiting Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
Condition: Familial Amyloid Polyneuropathy
Intervention: Drug: Fx-1006A
11 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
12 Completed Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
13 Completed Follow up and Observation of Charcot Marie Tooth Disease in Families
Condition: Charcot-Marie-Tooth Disease
Intervention:
14 Completed Nerve Entrapment in Diabetic Patients
Conditions: Carpal Tunnel Syndrome;   Entrapment Neuropathies;   Nerve Compression Syndromes;   Diabetes Complications
Intervention: Procedure: Outcome after carpal tunnel release
15 Recruiting Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis
Conditions: Familial Amyloid Polyneuropathy;   ATTR-PN
Intervention: Drug: Fx-1006A
16 Active, not recruiting An Open-Label Extension of Study Fx-005 Evaluating Long-Term Safety and Clinical Outcomes of Fx-1006A in Patients With Transthyretin Amyloid Transthyretin Amyloidosis With Polyneuropathy
Conditions: Familial Amyloid Polyneuropathy;   ATTR-PN
Intervention: Drug: Fx-1006A
17 Active, not recruiting High Dose Ascorbic Acid Treatment of CMT1A
Condition: Charcot-Marie-Tooth Disease, Type Ia
Interventions: Drug: Ascorbic acid (Vitamin C);   Drug: placebo
18 Completed Pain and Sensory Changes Assessment in HIV+ Patients
Condition: HIV Infections
Intervention:
19 Completed An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
20 Completed An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal agalsidase alfa;   Drug: Replagal

Previous Page Studies Shown (1-20) Next Page (21-26)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services